News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ruff Shamim
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Ruff Shamim (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 7,359 shares
@ $0
Disposed/sold 3,334 options to buy
@ $92.2, valued at
$307.4k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
Disposed/sold 780 options to buy
@ $146.01, valued at
$113.9k
Disposed/sold 443 options to buy
@ $34.76, valued at
$15.4k
Disposed/sold 1,405 options to buy
@ $34.76, valued at
$48.8k
Disposed/sold 576 options to buy
@ $93.61, valued at
$53.9k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2023 |
4
| Ruff Shamim (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 454 shares
@ $93.61, valued at
$42.5k
Granted 1,682 shares
@ $93.61, valued at
$157.5k
Granted 576 options to buy
@ $93.61, valued at
$53.9k
Granted 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 03/13/2023 |
4
| Ruff Shamim (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 5,740 shares
@ $83.73, valued at
$480.6k
Exercised 199 options to buy
@ $27.32, valued at
$5.4k
Exercised 1,326 options to buy
@ $34.76, valued at
$46.1k
Exercised 4,215 options to buy
@ $34.76, valued at
$146.5k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Ruff Shamim (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 118 shares
@ $27.32, valued at
$3.2k
Granted 199 options to buy
@ $27.32, valued at
$5.4k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2018 |
4
| Ruff Shamim (SVP, Chief Regulatory Affairs) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,305 shares
@ $89.22, valued at
$116.4k
Exercised 4,432 restricted stock units
@ $0 |
|
| 03/16/2018 |
4
| Ruff Shamim (SVP, Chief Regulatory Affairs) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 80 shares
@ $81.22, valued at
$6.5k
Paid exercise price by delivering 656 shares
@ $81.22, valued at
$53.3k
Exercised 469 options to buy
@ $13.9, valued at
$6.5k
Exercised 2,031 options to buy
@ $26.24, valued at
$53.3k
|
|
| 03/07/2018 |
4
| Ruff Shamim (SVP, Chief Regulatory Affairs) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 70,000 options to buy
@ $71.45, valued at
$5M
|
|
| 11/08/2017 |
4
| Ruff Shamim (SVP, Regulatory Affairs & Qual) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $55, valued at
$550k
Exercised 10,000 options to buy
@ $14.76, valued at
$147.6k
|
|
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/30/2016 |
4
| Ruff Shamim (SVP, Regulatory Affairs & Qual) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Sold 7,311 shares
@ $60, valued at
$438.7k
Exercised 7,311 options to buy
@ $13.9, valued at
$101.6k
|
|
|
|